Ali A. Zarrin

Trex (United States) — United States

Immunology and Microbiology · Life Sciences

24h-index3.5kcitations47works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(20), Immune Cell Function and Interaction(15), DNA Repair Mechanisms(6), NF-κB Signaling Pathways(6), Immune Response and Inflammation(5)

Publications47 total

Author response: Layilin regulates Treg motility and suppressive capacity in skin
2025Open Access
Layilin regulates Treg motility and suppressive capacity in skin
eLife·2025Open Access
Author response: Layilin Regulates Treg Motility and Suppressive Capacity in Skin
2025Open Access
Layilin Regulates Treg Motility and Suppressive Capacity in Skin
2025Open Access
Layilin regulates Treg motility and suppressive capacity in skin
eLife·2025· 2 citedOpen Access
Layilin Regulates Treg Motility and Suppressive Capacity in Skin
2024Open Access
In silico and multi-dimensional functional interrogation of tissue Tregs reveals novel therapeutics for autoimmunity and inflammation
The Journal of Immunology·2023Open Access
Treg specialization and functions beyond immune suppression
Clinical & Experimental Immunology·2022· 47 citedOpen Access
Activation-Induced Cytidine Deaminase Impacts the Primary Antibody Repertoire in Naive Mice
The Journal of Immunology·2022· 2 citedOpen Access
Tpl2 kinase regulates inflammation but not tumorigenesis in mice
Toxicology and Applied Pharmacology·2021· 1 cited
Editorial: The Role of Inhibitory Receptors in Inflammation and Cancer
Frontiers in Immunology·2020· 13 citedOpen Access
Kinase inhibition in autoimmunity and inflammation
Nature Reviews Drug Discovery·2020· 399 citedOpen Access
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells
Science Signaling·2020· 41 cited
TPL2 kinase action and control of inflammation
The Journal of Immunology·2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity
ACS Medicinal Chemistry Letters·2019· 23 citedOpen Access
CSF1R Ligands IL-34 and CSF1 Are Differentially Required for Microglia Development and Maintenance in White and Gray Matter Brain Regions
Frontiers in Immunology·2019· 189 citedOpen Access
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
Frontiers in Immunology·2019· 194 citedOpen Access
Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
Journal of Medicinal Chemistry·2019· 30 citedOpen Access
Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease
PLoS Genetics·2018· 86 citedOpen Access
Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease
2018· 13 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Frederick W. Alt(12), Kate Senger(10), Mariela Pauli(8), J. W. F. Valle(8), Yonglian Sun(7), Victoire Gouirand(6), Sean Clancy(6), Courtney Macon(6), Jarish N. Cohen(6), Maxime Kinet(6), Margaret M. Lowe(6), Samuel J. Lord(6), Kristen Skruber(6), Hobart W. Harris(6), Esther Kim(6), Isaac Neuhaus(6), Karin Reif(6), R. Dyche Mullins(6), John Manis(5), Swathi Sujatha-Bhaskar(5)